The European Joint Programme on Rare Diseases launched on December 12 the Joint Transnational Call 2023, a funding opportunity for research projects on the development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases.

This year’s topic is: “Natural History Studies addressing unmet needs in Rare Diseases”
The aim of the funding opportunity is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with expected impact to use the results in the future for benefit of patients.

Don’t miss out on the information webinar will be held on December 15th for potential applicants. Register here: https://forms.office.com/r/CLYFTuzRyw

Try the matchmaking tool to help you find your ideal project partner! (Under the tab Consortium makeup)

Pre-proposal submission deadline: 15^th February 2023

More information here https://www.ejprarediseases.org/joint-transnational-call-2023/

IRDiRC launches the Call for Members for the four new Task Forces of the 2023 Roadmap.

Check out the newly approved Task Forces:

• Funding Models to Support the Spectrum of Rare Disease Research and Development

The overall objective of this Task Force is to identify how different types of funders make decisions about when to fund at a given stage in a treatment’s development and the factors that contribute to this process.

More details on the candidates profiles: here.

• Framework to assess impacts associated with diagnosis, treatment, support, and community integration

The overall objective of this Task Force is to develop, operationalize, and test a comprehensive framework of holistic, multidimensional, and evolving life-long experiences of patients and families living with a rare disease.

More details on candidates profiles: here.

• Functional Analysis

The overall objective of this Task Force is to create a framework for the robust and effective ecosystem of functional analyses in rare diseases.

More details on candidates profiles: here.

• Preparing for genetic N-of-1 treatments of patients with ultra-rare mutations 

The overall objective of this Task Force is to connect different N-of-1+ efforts to reduce duplication, achieve global consensus and create a roadmap towards development and implementation of N-of-1+ treatment.

More details on candidates profiles: here.

How to Apply?

If you are interested in taking part in any of these activities please send a CV, biosketch, and letter of motivation (one paragraph each) to the IRDiRC Scientific Secretariat (scisec-irdirc@ejprarediseases.org) with the email title “TF Member Application-IRDiRC-Impacts” before 20 February 2023.